RecruitingNot ApplicableNCT05913622

A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support

Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane Oxygenation (REMAP ECMO) - Left Ventricular Unloading Study


Sponsor

Erasmus Medical Center

Enrollment

430 participants

Start Date

Jun 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

REMAP ECMO is a registry based platform in which multiple response adaptive randomized clinical trials (trial domains) will be embedded. These trial domains will, in a perpetual way, study the effects of a range of patient management strategies which aim to improve VA ECMO weaning success. A first trial domain will address the effects of left ventricular (LV) unloading through intra-aortic balloon pumping on weaning succes in VA ECMO supported patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Having received ECMO support for severe circulatory and/or respiratory insufficiency
  • Cardiogenic shock
  • Having received VA ECMO support for severe circulatory (and respiratory insufficiency).
  • Age ≥ 18 years
  • Initiation of LV unloading (IABP or Impella) possible ≤ 8 hours after ECMO initiation

Exclusion Criteria11

  • Objection to participation in the registry by the patient and/or proxy
  • VA ECMO usage confined to the period during surgery or another intervention (the VA ECMO was removed at the end of the intervention in the operation room).
  • No (deferred) informed consent provided by the patient and/or proxy.
  • Pregnancy
  • ECMO usage confined to the period during surgery or another intervention (the ECMO was removed at the end of the intervention).
  • Isolated right ventricular failure (e.g. due to pulmonary embolism).
  • Left ventricular assist device (LVAD), Impella or IABP in situ.
  • Ventricular septal defect or papillary muscle rupture as the cause of shock.
  • Thoracic or abdominal aortic dissection.
  • Moderate or severe aortic regurgitation
  • Mechanical prosthesis in mitral valve position

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntra-aortic balloon pump

An IABP is placed percutaneously into the thoracic aorta and supports the heart through synchronized inflation and deflation of a balloon.


Locations(14)

AZ Sint-Jan Brugge

Bruges, Belgium

ZOL Genk

Genk, Belgium

UZ Gent

Ghent, Belgium

Amphia hospital

Breda, North Brabant, Netherlands

Catharina hospital

Eindhoven, North Brabant, Netherlands

Amsterdam University Medical Center

Amsterdam, North Holland, Netherlands

Leiden University Medical Center

Leiden, South Holland, Netherlands

Erasmus Medical Center

Rotterdam, South Holland, Netherlands

Haga ziekenhuis

The Hague, South Holland, Netherlands

Antonius hospital

Nieuwegein, Utrecht, Netherlands

University Medical Center Utrecht

Utrecht, Utrecht, Netherlands

OLVG

Amsterdam, Netherlands

Maastricht UMC

Maastricht, Netherlands

Radboud UMC

Nijmegen, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05913622


Related Trials